Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America
- PMID: 21839900
- DOI: 10.1016/j.jval.2011.05.010
Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America
Abstract
Objective: To describe the development and validation of a health economic model (HEM) to address the tobacco disease burden and the cost-effectiveness of smoking cessation interventions (SCI) in seven Latin American countries.
Methods: The preparatory stage included the organization of the research network, analysis of availability of epidemiologic data, and a survey to health decision makers to explore country-specific information needs. The development stage involved the harmonization of a methodology to retrieve local relevant parameters and develop the model structure. Calibration and validation was performed using a selected country dataset (Argentina 2005). Predicted event rates were compared to the published rates used as model inputs. External validation was undertaken against epidemiologic studies that were not used to provide input data.
Results: Sixty-eight decision makers were surveyed. A microsimulation HEM was built considering the availability and quality of epidemiologic data and relevant outcomes conceived to suit the identified information needs of decision makers. It considers all tobacco-related diseases (i.e., heart, cerebrovascular and chronic obstructive pulmonary disease, pneumonia/influenza, lung cancer, and nine other neoplasms) and can incorporate individual- and population-level interventions. The calibrated model showed all simulated event rates falling within ± 10% of the sources (-9%-+5%). External validation showed a high correlation between published data and model results.
Conclusions: This evidence-based, internally and externally valid HEM for the assessment of the effects of smoking and SCIs incorporates a broad spectrum of tobacco related diseases, SCI, and benefit measures. It could be a useful policy-making tool to estimate tobacco burden and cost-effectiveness of SCI.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Health and Economic Impact of Health Warnings and Plain Tobacco Packaging in Seven Latin American Countries: Results of a Simulation Model.Nicotine Tob Res. 2020 Oct 29;22(11):2032-2040. doi: 10.1093/ntr/ntaa104. Nicotine Tob Res. 2020. PMID: 32531063 Review.
-
Cost effectiveness of full coverage of the medical management of smoking cessation in France.Tob Control. 2014 May;23(3):223-30. doi: 10.1136/tobaccocontrol-2012-050520. Epub 2012 Nov 29. Tob Control. 2014. PMID: 23197369
-
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20. Clin Ther. 2012. PMID: 22818870
-
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.Hosp Pract (1995). 2012 Feb;40(1):24-34. doi: 10.3810/hp.2012.02.945. Hosp Pract (1995). 2012. PMID: 22406880
-
Economic evaluations on cardiovascular preventive interventions in Argentina.Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):465-73. doi: 10.1586/erp.10.50. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20715922 Review.
Cited by
-
Exploring gender disparities in the disease and economic tobacco-attributable burden in Latin America.Front Public Health. 2024 Feb 12;11:1321319. doi: 10.3389/fpubh.2023.1321319. eCollection 2023. Front Public Health. 2024. PMID: 38414564 Free PMC article.
-
Tobacco Taxes as the Unsung Hero: Impact of a Tax Increase on Advancing Sustainable Development in Colombia.Int J Public Health. 2022 Mar 30;67:1604353. doi: 10.3389/ijph.2022.1604353. eCollection 2022. Int J Public Health. 2022. PMID: 35431761 Free PMC article.
-
The estimated benefits of increasing cigarette prices through taxation on the burden of disease and economic burden of smoking in Nigeria: A modeling study.PLoS One. 2022 Mar 2;17(3):e0264757. doi: 10.1371/journal.pone.0264757. eCollection 2022. PLoS One. 2022. PMID: 35235606 Free PMC article.
-
Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy.Int J Environ Res Public Health. 2021 May 11;18(10):5078. doi: 10.3390/ijerph18105078. Int J Environ Res Public Health. 2021. PMID: 34064880 Free PMC article.
-
Health burden and economic costs of smoking in Chile: The potential impact of increasing cigarettes prices.PLoS One. 2020 Aug 28;15(8):e0237967. doi: 10.1371/journal.pone.0237967. eCollection 2020. PLoS One. 2020. PMID: 32857819 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical